The Latest Breaking News from Pfizer

Until recently, the UK government limited a fourth dose of the COVID vaccine to people with severely weakened immune systems over the age of 16.

Pfizer offers $100 million to buy a ResApp, a company that has invented a smartphone app it says can diagnose COVID-19 by listening to someone cough.

Matisse Thybulle has only gotten one shot of the Pfizer vaccine and won’t be able to play in some of Philadelphia’s first-round games.

As India gears up to administer ‘precaution doses’ of COVID-19 vaccine to eligible population above 18 years from Sunday, the debate over ‘booster’ vs ‘precaution’ doses has arisen.

China is battling its biggest spike in coronavirus cases since the start of the pandemic, with millions under lockdown and the healthcare system feeling the pressure. One of the last countries sticking to a zero-Covid strategy, China aims to stamp out every infection with strict lockdowns and by sending all…

A whale with a lot of money to spend has taken a noticeably bearish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 47 strange trades.

Last December, we reported on the threatening behavior of a group of anti-vaccine activists toward Kristina Lawson, the president of the Medical Board of California.

The Therapeutic Goods Administration has approved the Pfizer COVID booster for people aged 12 to 15, but it will need a final tick of approval before it is made available to the cohort.

Egypt has received 1.5 million doses of Pfizer’s coronavirus vaccine donated by the US government. Acting Health Minister Khaled Abdel Ghaffar said Egypt received 1,501,110 Pfizer COVID-19 vaccine doses gifted by the US and delivered through the COVAX initiative and in cooperation with the Vaccine Alliance (GAVI). The new batch…

Pfizer Inc (NYSE: PFE) shares are trading higher Thursday. The company announced the acquisition of ReViral for a total consideration of up to $525 million.

Pharma giant Pfizer, Inc. (NYSE: PFE), which has found huge success with its COVID franchise, is now looking to conquer another frontier.